Pharmaceuticals

AbbVie and Gilgamesh Pharmaceuticals agree to terms of collaboration to develop advanced treatments for mental illnesses

bexib
By bexib 0 Min Read

This joint venture aims to address unmet needs in the treatment of mood and anxiety disorders through novel neuroplastogens.

You Might Also Like

Pharma Pulse 8/20/24: CRAACO Evolution, Pain Relief for HIV-Infected People and More

The health care system is changing. How should we respond?

FDA approves Tris Pharma’s Onyda XR, a once-daily extended-release oral suspension for the treatment of ADHD

Premera Blue Cross appoints Dr. Romila Batra as Chief Medical Officer

Shellac imaging agent represents breakthrough in endometriosis detection

Share This Article
Previous Article Fiat Debases Marriage
Next Article Zone management with Wes Anderson and Johanna Lindeboom – RealAgriculture
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

China’s seapower expands as US shipyards decline
Manufacturing
Print advertising is an e-commerce opportunity
Retail & E-commerce
Top 6 banking trends to grow across Asia in 2025
Fintech
The Difference Between Direct Carrier Appointments and Producer Sub-Codes
Insurance